As of 4:00pm ET
| -0.55 / -0.71%|
The 21 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 103.00, with a high estimate of 140.00 and a low estimate of 75.00. The median estimate represents a +34.34% increase from the last price of 76.67.
The current consensus among 26 polled investment analysts is to Hold stock in Vertex Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.